Safe Supply Streaming Co. Closes Strategic Private Placement

Vancouver, British Columbia–(Newsfile Corp. – August 1, 2023) – Safe Supply Streaming Co. Ltd. (“Safe Supply” or “SSSC” or “the Company”), the leading global pharmaceutical and healthcare streaming company focused on the third wave of the ongoing international de-scheduling of narcotics and plant medicine, is pleased to announce that it has closed a strategic private placement offering (the “Offering“) of 5,965,000 subscription receipts of the Company (“Subscription Receipts“) at a price of $0.40 per Subscription Receipt for aggregate gross proceeds of approximately $2,386,000.

The Company intends to use net proceeds from the Offering for general corporate purposes and to make investments into the emerging Safe Supply ecosystem tackling the system illicit drug problem worldwide. Additionally the completion of the offering is a major milestone for the Company as it seeks a listing on the CSE.

Safe Supply’s CEO, Bill Panagiotakopoulos, commented:

“I am thrilled to share this momentous occasion with all of you. Safe Supply is paving the way for the third wave of de-scheduling in Canada, with a global focus on addressing harm reduction and addiction treatment. Our commitment to partnering with governments in the fight against the fentanyl overdose crisis is resolute.

Today, I am delighted to announce the successful closing of our strategic financing, a significant step forward in our journey towards going public on the CSE. With the support of renowned shareholders and advisors, we are on track to become the world leader in this exciting new industry.

Our unwavering dedication to creating a safer supply chain and tackling the challenges of addiction has been the driving force behind our achievements. We firmly believe that by combining our expertise with cutting-edge solutions, we can make a tangible impact on the lives of countless individuals struggling with addiction.

Safe Supply is proud to stand at the forefront of change, aiming to shape a brighter future for communities across the globe. Together, we will forge a path towards a safer and healthier tomorrow. I extend my sincere gratitude to all our supporters, partners, and stakeholders who have been instrumental in making this possible.

Let us continue this journey with determination and compassion, knowing that our efforts will create a lasting legacy that benefits society as a whole.“

Details of the Offering

The Offering consisted of a brokered private placement by Research Capital Corporation as sole agent and sole bookrunner (the “Agent” or “RCC“) on a commercially reasonable “best efforts” basis of 2,450,000 Subscription Receipts for aggregate gross proceeds of $980,000 (the “Brokered Offering“) and a concurrent non-brokered private placement of subscription receipts for aggregate gross proceeds of $1,406,000 (the “Non-Brokered Offering“). The Offering was completed in connection with a business combination transaction (the “Transaction“) with Origin Therapeutics Holdings Inc. (“Origin“), that will constitute a reverse takeover of Origin by Safe Supply, and which is expected to result in the listing of the shares (the “Resulting Issuer Shares“) of the issuer that will exist upon completion of the Transaction (the “Resulting Issuer“) on the Canadian Securities Exchange (the “CSE“).

Safe Supply may increase the size of the Offering, provided that the total Subscription Receipts issued under the Offering does not exceed 10,000,000, and the aggregate gross proceeds raised under the offering does not exceed $4,000,000. Any such increase in the size of the Offering may be completed under the Brokered Offering, the Non-Brokered Offering, or both and may take place in one or more tranches.

Upon the satisfaction of certain escrow release conditions (the “Escrow Release Conditions“), each Subscription Receipt shall be automatically converted, without any further action by the holder of such Subscription Receipt (and for no additional consideration), and subject to adjustment in certain circumstances, for one common share in the capital of Safe Supply (each, an “Underlying Share“). Each Underlying Share will be subsequently automatically exchanged, without payment of any ‎additional consideration or further action on the part of the holder, for one Resulting Issuer Share (as defined below).

The gross proceeds of the Offering, net of the Agents’ expenses incurred as of the closing (the “Escrowed Funds“), are being held in escrow pursuant to the terms of a subscription receipt agreement dated August 1, 2023 between Safe Supply, Origin, the Agent and Olympia Trust Company, as registrar and transfer agent for the Subscription Receipts and as escrow agent for the Escrowed Funds (the “Subscription Receipt Agreement“). Upon satisfaction or waiver of the Escrow Release Conditions, the Escrowed Funds together with any interest earned thereon, will be released to Safe Supply (and the Agent in respect of the Agent’s Fee (as defined below), Agent’s Advisory Fee (as defined below) and Agent’s expenses incurred following the closing) in accordance with the terms set out in the Subscription Receipt Agreement. If the Escrow Release Conditions are not satisfied or waived within 120 days following closing of the Offering (or as extended in accordance with the terms of the Subscription Receipt Agreement), the Subscription Receipts will be cancelled without any further action and the Escrowed Funds together with any interest earned thereon will be returned to subscribers on a pro rata basis.

In connection with the Offering, (i) following the satisfaction of the Escrow Release Conditions, the Agent will also receive an aggregate cash fee equal to $68,600 (the “Agent’s Fee“). The Agent was also issued 77,750 compensation options (the “Compensation Options“), each exercisable to acquire one underlying Common Share (or common share of the resulting issuer following the completion of the Transaction) for a period of 24 months following the listing of the resulting issuer’s common shares on the CSE; and (ii) the Agent will receive an advisory fee equal to $49,210 and 246,050 advisory warrants (the “Advisory Warrants“), for providing advice and assistance in connection with the non-brokered portion of the Offering. Each Advisory Warrant is exercisable to acquire one underlying Common Share (or common share of the resulting issuer following completion of the Transaction), on the same terms as the Compensation Options.

Subscribers in the Offering entered into lock-up agreements restricting the sale, transfer, pledge, assignment, or other disposal of any securities of the Safe Supply or the Resulting Issuer owned, directly or indirectly by such subscriber (subject to customary exceptions for (a) transfers among affiliates for tax or other planning purposes and (b) tenders to a bona fide takeover bid) for a period of six (6) months. Under the lock-up agreement, 50% of the subject securities will be released upon listing of the Resulting Issuer Shares on the CSE and the remaining 50% will released on the date that is six (6) months after the Listing Date.

About Safe Supply Streaming Co

Safe Supply Streaming is the pre-eminent company tackling the systemic illicit drug problem that has been plaguing society for over 50 years. We are a healthcare / pharmaceutical investment company that is led by a world-class management team with decades of experience operating in regulated markets.

Our company is focused on working with Health Canada, and all levels of the Canadian Government to invest, finance, partner, and/or joint venture with a portfolio of companies that operate across the Safe Supply ecosystem.

This ecosystem is vast and includes opportunities in: laboratories, import/export of regulated products, manufacturing and processing of regulated products, government sponsored real estate, rehabilitation facilities, pharmaceutical development, treatment clinics and more. This burgeoning ecosystem is being designed, with oversight from local, provincial and federal government agencies, to curb the socioeconomic harm caused by the illicit drug supply which is causing deaths at an increasingly alarming rate.

On behalf of the board of directors

Bill Panagiotakopoulos, Chief Executive Officer and Director,
Safe Supply Streaming Co. Ltd.
info@safesupplystreaming.com

For more information

Marc Lakmaaker
AdvanceCap Inc
T: +1.647.289.6640
E: marc@advancecapinc.com

Forward-Looking Information and Statements

Certain statements in this news release related to the Company are forward-looking statements and are prospective in nature, including but not limited to the express or implied statements and assumptions regarding the intention of Origin and Safe Supply to complete the Transaction and the Private Placement. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. In particular, there is no guarantee that the parties will successfully enter into the Definitive Agreement or complete the Transaction or Private Placement contemplated herein, that Origin will obtain any of the required shareholder or regulatory approvals, including the listing of the Resulting Issuer Shares on the CSE. These forward-looking statements generally can be identified by the use of forward-looking words such as “may”, “should”, “could”, “intend”, “estimate”, “plan”, “anticipate”, “expect”, “believe”, “will” or “continue”, or the negative thereof or similar variations. There are numerous risks and uncertainties that could cause actual results and the Company’s and Safe Supply’s plans and objectives to differ materially from those expressed in the forward-looking information, including but not limited to adverse market conditions and risks inherent in the Company’s and Safe Supply’s business in general. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this press release. Except as required by applicable law, the Company and Safe Supply do not intend to update these forward-looking statements.

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/175740